Effective follow-up strategies in soft tissue sarcoma

Seminars in Surgical Oncology

Volumn 17, Issue 1, 1999, Pages 83-87

  Whooley, Brian P ^a   Mooney, Margaret M ^a   Gibbs, John F ^a   Kraybill, William G ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Blood cell count; Chest radiography; Combined modality therapy; Cost benefit analysis; Disease free survival; Emission computed tomography magnetic resonance imaging; Follow up studies; Local neoplasm recurrence; Lymph node metastasis; Neoplasm metastasis; Prognosis; Quality adjusted life years; Recurrence; Sarcoma; Soft tissue neoplasms; Survival rate; X ray computed tomography

Indexed keywords

CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SOFT TISSUE SARCOMA; THORAX RADIOGRAPHY; TUMOR LOCALIZATION;

CONTINUITY OF PATIENT CARE; COST-BENEFIT ANALYSIS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; SARCOMA; SOFT TISSUE NEOPLASMS;

EID: 0033014961     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199907/08)17:1<83::AID-SSU11>3.0.CO;2-W     Document Type: Review

References (26)

1. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1999. CA Cancer J Clin 1999;49:8-31.
2. Lawrence W Jr, Donegan WL, Natarajan N, et al: Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons. Ann Surg 1987;205:349-359.
3. Pisters PW, Leung DH, Woodruff J, et al: Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol 1996;14:1679-1689.
4. Huth JF, Eilber FR: Patterns of metastatic spread following resection of extremity soft-tissue sarcomas and strategies for treatment. Semin Surg Oncol 1988;4:20-26.
5. Gadd MA, Casper ES, Woodruff JM, et al: Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma [Review]. Ann Surg 1993;218:705-712.
6. Fong Y, Coit DC. Woodruff JM, Brennan MF: Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg 1993;217:72-77.
7. Potter DA, Glenn J, Kinsella T, et al: Patterns of recurrence in patients with high-grade soft-tissue sarcomas. J Clin Oncol 1985;3:353-366.
8. Jaques DP, Coit DG, Hajdu SI, Brennan MF: Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg 1990;212:51-59.
9. Conlon KC, Casper ES, Brennan MF. Primary gastrointestinal sarcomas: analysis of prognostic variables. Ann Surg Oncol 1995;2:26-31.
10. Singer S, Antman K, Corson JM, Eberlein TJ: Long-term salvage-ability for patients with locally recurrent soft-tissue sarcomas. Arch Surg 1992;127:548-554.
11. Pisters PW, Brennan MF: Soft tissue sarcomas. In Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE (eds): "Clinical oncology." New York: Churchill Livingstone; 1995. p. 1799-1832.
12. th ed. Baltimore: Williams & Wilkins; 1997. p. 2559-2589.
13. van Geel AN, Pastorino U, Jauch KW, et al: Surgical treatment of lung metastases: the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma group study of 255 patients. Cancer 1996;77:675-682.
14. Putnam JB Jr, Suell DM, Natarajan G, Roth JA: Extended resection of pulmonary metastases: is the risk justified? Ann Thorac Surg 1993;55:1440-1446.
15. Karakousis CP, Blumenson LE, Canavese G, Rao U: Surgery for disseminated abdominal sarcoma. Am J Surg 1992;163:560-564.
16. Adjuvant chemotherapy for localized resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet 1997;350(9092):1647-1654.
17. Elias A, Ryan L, Sulkes A, et al: Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy. J Clin Oncol 1989;7:1208-1216.
18. Kole AC, Nieweg OE, van Ginkel RJ, et al: Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [18F] fluorodeoxyglucose. Ann Surg Oncol 1997;4:57-63.
19. Lucas JD, O'Doherty MJ, Wong JC, et al: Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas. J Bone Joint Surg [Br] 1998;80: 441-447.
20. nd annual meeting; 1999 Mar 4-7; Orlando, Florida. pp. 30 (No. 87).
21. Russell LB, Gold MR, Siegel JE, et al: The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine [Review]. JAMA 1996;276:1172-1177.
22. Laupacis A, Feeny D, Detsky AS, Tugwell PX: How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992;146:473-481.
23. Mooney MM, Mettlin C, Michalek AM, et al: Life-long screening of patients with intermediate-thickness cutaneous melanoma for asymptomatic pulmonary recurrences: a cost-effectiveness analysis. Cancer 1997;80:1052-1064.
24. Fleming JB, Holtz D, Cantor SB, et al: The utility and cost-effectiveness of computerized tomography (CT) to screen for pulmonary metastases in patients presenting with T1 extremity soft tissue sarcoma (STS). [Abstract] In Proc Am Soc Clin Oncol 1998;17:Abstract 1989.
25. Frame PS, Fryback DG, Patterson C: Screening for abdominal aortic aneurysm in men ages 60 to 80 years. A cost-effectiveness analysis. Ann Intern Med 1993;119:411-416.
26. Salzmann P, Kerlikowske K, Phillips K: Cost-effectiveness of extending screening mammography to include women 40 to 49 years of age [published erratum appears in Ann Intern Med 1998;128:878]. Ann Intern Med 1997;127:955-965.